Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 14 Temozolomide 10 Specimen Handling 10 X-Rays 8 Radiotherapy 7 Biopsy 7 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 trametinib 4 ulixertinib 3 olaparib 3 larotrectinib 3 erdafitinib 3 dabrafenib 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 tipifarnib 2 selpercatinib 2 pembrolizumab 2 palbociclib 2 niraparib 2 ivosidenib 2 ensartinib 2 atezolizumab 2 abemaciclib 2 Surveys and Questionnaires 2 Radiation 2 Proton Therapy 2 Lomustine 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioma × Imiquimod × Clear all

NCT04808245 2025-09-22

INTERCEPT-H3

German Cancer Research Center

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡